WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Up – What’s Next?

Posted by Casey Walker on Nov 6th, 2026

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) gapped up before the market opened on Wednesday. The stock had previously closed at $11.25, but opened at $12.30. WuXi Biologics (Cayman) shares last traded at $12.6120, with a volume of 7,558 shares.

Analyst Ratings Changes

Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, WuXi Biologics (Cayman) has a consensus rating of “Hold”.

Read Our Latest Analysis on WXXWY

WuXi Biologics (Cayman) Trading Down 2.2%

The company’s 50-day moving average is $12.79 and its 200-day moving average is $10.24.

WuXi Biologics (Cayman) Company Profile

(Get Free Report)

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.

Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.